Jeil rekindling strategic alliance flame

Published: 2012-10-10 06:59:00

Updated: 2012-10-10 06:59:00

Jeil Pharmaceutical is actively seeking strategic alliances with a number of multinational pharmaceutical firms using its strong sales and marketing force.

Jeil said Monday that it has agreed with Lundbeck Korea to jointly market Lexapro (escitalopram oxalate) under their first strategic alli...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK